32 employees
Tercica, a biotechnology company, develops and commercializes therapeutics for the treatment of endocrine and metabolic diseases.
1929
$75M
from 3 investors over 3 rounds
Ipsen NA raised $75M on October 14, 2005
Investors: KINGSBRIDGE CAPITAL ADVISORS LIMITED
Ipsen NA raised $44M on July 18, 2003
Investors: Prospect Venture Partners, LP and MPM Capital